Economy
Amgen's Lung Cancer Trial Tests the Limits of Survival
Amgen drug combined with immunotherapy extends survival in lung cancer trial, according to Reuters and Fierce Pharma. The new findings from the trial showcase a massive survival benefit at ESMO, marking a critical turning point for the company and patients alike.